BioCentury | Mar 22, 2012
Tools & Techniques

Monkeys bridge the stroke gap

...EPO), is in Phase I testing. Lundbeck is co-developing the therapies with Bayer AG and Warren Pharmaceuticals Inc....
...Toronto Western Research Institute , Toronto, Ontario, Canada University of Toronto , Toronto, Ontario, Canada Warren Pharmaceuticals Inc....
BioCentury | Jan 13, 2011
Targets & Mechanisms

EPO plays defense

...issues, the findings could add a new indication for tissue-protecting erythropoietin mimetics being developed by Warren Pharmaceuticals Inc....
...Center , Omaha, Ne.   University of Toronto , Toronto, Ontario, Canada   Warren Pharmaceuticals Inc....
BioCentury | Jan 13, 2011
Distillery Therapeutics

Indication: Endocrine disease

...At least six companies market EPO or EPO analogs to treat anemia. Shire plc and Warren Pharmaceuticals Inc....
BioCentury | Nov 9, 2009
Clinical News

Lu AA24493: Phase IIa started

...to Lu AA24493 for CNS-related indications from Warren in 2002 (see BioCentury, Feb. 25, 2002). Warren Pharmaceuticals Inc....
BioCentury | May 18, 2009
Clinical News

Lu AA24493: Phase I started

...to Lu AA24493 for CNS-related indications from Warren in 2002 (see BioCentury, Feb. 25, 2002). Warren Pharmaceuticals Inc....
BioCentury | Nov 19, 2007
Strategy

Reloading in a hurry

...a Phase I study in acute ischemic stroke in October. LUN in-licensed the compound from Warren Pharmaceuticals Inc....
BioCentury | Oct 22, 2007
Clinical News

Lu AA24493: Phase I started

...the central nervous system from Warren under a 2002 agreement (see BioCentury, Feb. 25, 2002). Warren Pharmaceuticals Inc....
BioCentury | Oct 9, 2006
Company News

Shire Pharmaceuticals Group plc, Warren deal

...Europe in the first half of 2007. Shire Pharmaceuticals Group plc (LSE:SHP; SHPGY), Basingstoke, U.K. Warren Pharmaceuticals Inc....
BioCentury | Oct 9, 2006
Tools & Techniques

EPOtecting tissue

...to stimulate red blood cells has resulted in several blockbuster drugs to treat anemia. But Warren Pharmaceuticals Inc....
BioCentury | Jul 12, 2004
Clinical News

Warren, Lundbeck preclinical data

...did not show any hematopoietic activity in culture or in dosing in different animal species. Warren Pharmaceuticals Inc....
Items per page:
1 - 10 of 14
BioCentury | Mar 22, 2012
Tools & Techniques

Monkeys bridge the stroke gap

...EPO), is in Phase I testing. Lundbeck is co-developing the therapies with Bayer AG and Warren Pharmaceuticals Inc....
...Toronto Western Research Institute , Toronto, Ontario, Canada University of Toronto , Toronto, Ontario, Canada Warren Pharmaceuticals Inc....
BioCentury | Jan 13, 2011
Targets & Mechanisms

EPO plays defense

...issues, the findings could add a new indication for tissue-protecting erythropoietin mimetics being developed by Warren Pharmaceuticals Inc....
...Center , Omaha, Ne.   University of Toronto , Toronto, Ontario, Canada   Warren Pharmaceuticals Inc....
BioCentury | Jan 13, 2011
Distillery Therapeutics

Indication: Endocrine disease

...At least six companies market EPO or EPO analogs to treat anemia. Shire plc and Warren Pharmaceuticals Inc....
BioCentury | Nov 9, 2009
Clinical News

Lu AA24493: Phase IIa started

...to Lu AA24493 for CNS-related indications from Warren in 2002 (see BioCentury, Feb. 25, 2002). Warren Pharmaceuticals Inc....
BioCentury | May 18, 2009
Clinical News

Lu AA24493: Phase I started

...to Lu AA24493 for CNS-related indications from Warren in 2002 (see BioCentury, Feb. 25, 2002). Warren Pharmaceuticals Inc....
BioCentury | Nov 19, 2007
Strategy

Reloading in a hurry

...a Phase I study in acute ischemic stroke in October. LUN in-licensed the compound from Warren Pharmaceuticals Inc....
BioCentury | Oct 22, 2007
Clinical News

Lu AA24493: Phase I started

...the central nervous system from Warren under a 2002 agreement (see BioCentury, Feb. 25, 2002). Warren Pharmaceuticals Inc....
BioCentury | Oct 9, 2006
Company News

Shire Pharmaceuticals Group plc, Warren deal

...Europe in the first half of 2007. Shire Pharmaceuticals Group plc (LSE:SHP; SHPGY), Basingstoke, U.K. Warren Pharmaceuticals Inc....
BioCentury | Oct 9, 2006
Tools & Techniques

EPOtecting tissue

...to stimulate red blood cells has resulted in several blockbuster drugs to treat anemia. But Warren Pharmaceuticals Inc....
BioCentury | Jul 12, 2004
Clinical News

Warren, Lundbeck preclinical data

...did not show any hematopoietic activity in culture or in dosing in different animal species. Warren Pharmaceuticals Inc....
Items per page:
1 - 10 of 14